Authors Key Contacts | |
---|---|
Issue | Aug 13, 2025 |
Practice Areas |
IP & Technology Newsletter Vol.2 (2025) has been published.
Contents
・Judgment of the Intellectual Property High Court that ordered generic drug manufacturers to pay over JPY 20 billion for the infringement of a patent right, the term of which was extended based on an originator drug containing nalfurafine hydrochloride as its active ingredient.
(Intellectual Property High Court Judgment on May 27, 2025 (2025 (Ne) No. 10037, Appeal Case for Patent Infringement Injunction, etc.))